| Molecular farming in plants: host systems and expression technology RM Twyman, E Stoger, S Schillberg, P Christou, R Fischer TRENDS in Biotechnology 21 (12), 570-578, 2003 | 921 | 2003 |
| Plant-based production of biopharmaceuticals R Fischer, E Stoger, S Schillberg, P Christou, RM Twyman Current opinion in plant biology 7 (2), 152-158, 2004 | 872 | 2004 |
| Transient expression of a tumor-specific single-chain fragment and a chimeric antibody in tobacco leaves C Vaquero, M Sack, J Chandler, J Drossard, F Schuster, M Monecke, ... Proceedings of the National Academy of Sciences 96 (20), 11128-11133, 1999 | 422 | 1999 |
| Molecular farming for new drugs and vaccines: current perspectives on the production of pharmaceuticals in transgenic plants JKC Ma, E Barros, R Bock, P Christou, PJ Dale, PJ Dix, R Fischer, J Irwin, ... EMBO reports 6 (7), 593-599, 2005 | 363 | 2005 |
| GMP issues for recombinant plant-derived pharmaceutical proteins R Fischer, S Schillberg, S Hellwig, RM Twyman, J Drossard Biotechnology advances 30 (2), 434-439, 2012 | 251 | 2012 |
| Transgenic plants in the biopharmaceutical market RM Twyman, S Schillberg, R Fischer Expert opinion on emerging drugs 10 (1), 185-218, 2005 | 242 | 2005 |
| Critical analysis of the commercial potential of plants for the production of recombinant proteins S Schillberg, N Raven, H Spiegel, S Rasche, M Buntru Frontiers in Plant Science 10, 2019 | 241 | 2019 |
| Molecular farming of recombinant antibodies in plants S Schillberg, R Fischer, N Emans Cellular and Molecular Life Sciences CMLS 60, 433-445, 2003 | 227 | 2003 |
| Opportunities for recombinant antigen and antibody expression in transgenic plants—technology assessment S Schillberg, RM Twyman, R Fischer Vaccine 23 (15), 1764-1769, 2005 | 211 | 2005 |
| Molecular farming of recombinant antibodies in plants R Fischer, YC Liao, K Hoffmann, S Schillberg, N Emans Walter de Gruyter 380 (7-8), 825-839, 1999 | 191 | 1999 |
| Potential applications of plant biotechnology against SARS-CoV-2 T Capell, RM Twyman, V Armario-Najera, JKC Ma, S Schillberg, ... Trends in plant science 25 (7), 635-643, 2020 | 188 | 2020 |
| Apoplastic and cytosolic expression of full‐size antibodies and antibody fragments in Nicotiana tabacum S Schillberg, S Zimmermann, A Voss, R Fischer Transgenic research 8, 255-263, 1999 | 178 | 1999 |
| Intracellular expression of TMV-specific single-chain Fv fragments leads to improved virus resistance in shape Nicotiana tabacum S Zimmermann, S Schillberg, YC Liao, R Fisher Molecular Breeding 4, 369-379, 1998 | 172 | 1998 |
| Patterns of CRISPR/Cas9 activity in plants, animals and microbes L Bortesi, C Zhu, J Zischewski, L Perez, L Bassié, R Nadi, G Forni, ... Plant Biotechnology Journal, 2016 | 162 | 2016 |
| Production of antibodies in plants and their use for global health R Fischer, RM Twyman, S Schillberg Vaccine 21 (7-8), 820-825, 2003 | 160 | 2003 |
| Characteristics of genome editing mutations in cereal crops C Zhu, L Bortesi, C Baysal, RM Twyman, R Fischer, T Capell, S Schillberg, ... Trends in Plant Science 22 (1), 38-52, 2017 | 150 | 2017 |
| Towards molecular farming in the future: moving from diagnostic protein and antibody production in microbes to plants R Fischer, J Drossard, U Commandeur, S Schillberg, N Emans Biotechnology and Applied Biochemistry 30 (2), 101-108, 1999 | 150 | 1999 |
| Expression and characterization of bispecific single‐chain Fv fragments produced in transgenic plants R Fischer, D Schumann, S Zimmermann, J Drossard, M Sack, ... European Journal of Biochemistry 262 (3), 810-816, 1999 | 149 | 1999 |
| Commercial aspects of pharmaceutical protein production in plants R Fischer, S Schillberg, J F Buyel, R M Twyman Current pharmaceutical design 19 (31), 5471-5477, 2013 | 146 | 2013 |
| Molecular farming of pharmaceutical proteins using plant suspension cell and tissue cultures S Schillberg, N Raven, R Fischer, R M Twyman, A Schiermeyer Current pharmaceutical design 19 (31), 5531-5542, 2013 | 136 | 2013 |
